Journal article
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
Abstract
BACKGROUND: Angiotensin-converting-enzyme inhibitors improve the outcome among patients with left ventricular dysfunction, whether or not they have heart failure. We assessed the role of an angiotensin-converting-enzyme inhibitor, ramipril, in patients who were at high risk for cardiovascular events but who did not have left ventricular dysfunction or heart failure.
METHODS: A total of 9297 high-risk patients (55 years of age or older) who had …
Authors
Yusuf S; Sleight P; Pogue J; Bosch J; Davies R; Dagenais G
Journal
New England Journal of Medicine, Vol. 342, No. 3, pp. 145–153
Publisher
Massachusetts Medical Society
Publication Date
January 20, 2000
DOI
10.1056/nejm200001203420301
ISSN
0028-4793